Neuland Labs - Neuland Laboratories Share Price

14,620.00-85.00 (-0.58%)
Volume: 32

Pre Open
Last Updated On: 13 Jan, 2026, 09:05 AM IST

TECHNICALS
COMPARE

14,620.00-85.00 (-0.58%)
Volume: 32

Stock Recommendations

Potential
Upside*
1 Year
Target

STRONG BUY

Mean Recos by
4 Analysts

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

/10

Stock Score

View Report

Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum

No Rating (NR)

Negative

Neutral

Positive

Unlock Stock Score

* Investments in securities are subject to market risks. These are indicative and should not be interpreted as investment advice or guaranteed returns.

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Key Metrics

PE Ratio

(x)

78.56

EPS - TTM

(₹)

187.18

MCap

(₹ Cr.)

18,866.35

Sectoral MCap Rank

PB Ratio

(x)

12.37

Div Yield

(%)

0.08

Face Value

(₹)

10.00

Beta

0.44

VWAP

(₹)

0.00

52W H/L

(₹)

19,747.00 / 10,190.70

Neuland Labs share price insights

View All

Intraday fact check
In the last 17 years, only 4.97 % trading sessions saw intraday declines higher than 5 % .
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 71.68%, which is highest in the last 3 years. (Source: Consolidated Financials)
Stock Screener Highlights
Neuland Labs is a part of Mid-cap Growth Stocks Screener
Topline Contraction
Sales de-grew by 4.7%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
Neuland Labs Share Price Update
Neuland Laboratories Ltd. share price moved down by -0.58% from its previous close of Rs 14,705.00. Neuland Laboratories Ltd. stock last traded price is 14,620.00
Share Price Value
Today/Current/Last 14,620.0015,000.00
Previous Day 14,705.0014,708.55

Share Price	Value
Today/Current/Last	14,620.0015,000.00
Previous Day	14,705.0014,708.55

InsightsNeuland Labs

Do you find these insights useful?

hate it
meh
love it

Neuland Labs Share Price Returns

1 Day	-0.58%
1 Week	0.77%
1 Month	-9.07%
3 Months	-10.39%
1 Year	11.48%
3 Years	764.65%
5 Years	1079.6%

ET Stock ScreenersTop Score Companies

Check whether Neuland Labs belongs to analysts' top-rated companies list?

View Stock Screeners

News & Analysis

View all Neuland Labs Share News & Announcements

Share Recommendations

Recent Recos

STRONG BUY

Current

Mean Recos by 4 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹920
OrganizationHDFC Securities
BUY

Target₹1000
OrganizationHDFC Securities
BUY

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	2	2	2	1
Buy	2	2	2	2
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	4	4	4	3

View all Stock Recommendations

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 71.68%, which is highest in the last 3 years. (Source: Consolidated Financials)
Topline Contraction
Sales de-grew by 4.7%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

Quarterly \| Annual	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total Income	516.07	300.61	335.82	401.94	315.18
Total Income Growth (%)	71.68	-10.49	-16.45	27.53	-29.08
Total Expenses	381.27	278.45	294.18	271.96	264.69
Total Expenses Growth (%)	36.92	-5.35	8.17	2.74	-15.14
EBIT	134.80	22.16	41.65	129.98	50.49
EBIT Growth (%)	508.45	-46.80	-67.96	157.46	-61.90
Profit after Tax (PAT)	96.85	13.90	27.81	101.59	32.84
PAT Growth (%)	596.79	-50.01	-72.63	209.31	-66.44
EBIT Margin (%)	26.12	7.37	12.40	32.34	16.02
Net Profit Margin (%)	18.77	4.62	8.28	25.27	10.42
Basic EPS (₹)	75.49	10.83	21.67	79.18	25.60

Quarterly \| Annual	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total Income	516.07	300.61	335.82	401.94	315.18
Total Income Growth (%)	71.68	-10.49	-16.45	27.53	-29.08
Total Expenses	381.69	278.65	294.50	272.18	265.57
Total Expenses Growth (%)	36.98	-5.38	8.20	2.49	-14.72
EBIT	134.38	21.96	41.33	129.76	49.60
EBIT Growth (%)	511.91	-46.86	-68.15	161.61	-62.70
Profit after Tax (PAT)	96.46	13.71	27.73	101.39	31.96
PAT Growth (%)	603.69	-50.57	-72.65	217.27	-67.50
EBIT Margin (%)	26.04	7.31	12.31	32.28	15.74
Net Profit Margin (%)	18.69	4.56	8.26	25.23	10.14
Basic EPS (₹)	75.18	10.68	21.62	79.03	24.91

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,497.35	1,571.12	1,200.95	953.15	953.01
Total Revenue Growth (%)	-4.70	30.82	26.00	0.02	24.32
Total Expenses	1,227.42	1,169.69	985.20	870.99	847.67
Total Expenses Growth (%)	4.94	18.73	13.11	2.75	18.78
Profit after Tax (PAT)	260.11	300.08	163.52	63.82	80.63
PAT Growth (%)	-13.32	83.51	156.21	-20.85	397.40
Operating Profit Margin (%)	18.83	26.65	19.20	10.05	13.15
Net Profit Margin (%)	17.61	19.25	13.72	6.71	8.60
Basic EPS (₹)	202.74	233.89	127.45	49.74	62.85

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,497.35	1,571.12	1,200.95	953.15	953.01
Total Revenue Growth (%)	-4.70	30.82	26.00	0.02	24.32
Total Expenses	1,228.38	1,170.36	985.73	871.41	848.05
Total Expenses Growth (%)	4.96	18.73	13.12	2.76	18.76
Profit after Tax (PAT)	259.43	299.60	163.12	63.53	80.29
PAT Growth (%)	-13.41	83.67	156.75	-20.87	405.63
Operating Profit Margin (%)	18.77	26.61	19.16	10.01	13.11
Net Profit Margin (%)	17.56	19.22	13.69	6.68	8.57
Basic EPS (₹)	202.20	233.51	127.14	49.52	62.58

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,179.88	1,832.56	1,579.76	1,383.49	1,324.79
Total Assets Growth (%)	18.95	16.00	14.19	4.43	7.62
Total Liabilities	655.08	549.86	585.67	542.99	538.33
Total Liabilities Growth (%)	19.14	-6.11	7.86	0.87	3.32
Total Equity	1,524.81	1,282.70	994.10	840.50	786.46
Total Equity Growth (%)	18.87	29.03	18.27	6.87	10.78
Current Ratio (x)	2.45	2.15	1.73	1.60	1.49
Total Debt to Equity (x)	0.09	0.06	0.12	0.28	0.18
Contingent Liabilities	92.22	140.47	100.72	92.99	127.52

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,178.17	1,830.93	1,579.34	1,382.12	1,323.52
Total Assets Growth (%)	18.97	15.93	14.27	4.43	7.63
Total Liabilities	660.38	554.39	590.97	546.55	541.64
Total Liabilities Growth (%)	19.12	-6.19	8.13	0.91	3.33
Total Equity	1,517.79	1,276.54	988.36	835.57	781.88
Total Equity Growth (%)	18.90	29.16	18.29	6.87	10.82
Current Ratio (x)	2.41	2.12	1.71	1.58	1.47
Total Debt to Equity (x)	0.09	0.06	0.12	0.28	0.19
Contingent Liabilities	92.22	140.47	100.72	92.99	127.52

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Increase in Cash from Investing
Company has used Rs 298.16 cr for investing activities which is an YoY increase of 99.19%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	317.38	261.18	237.21	58.58	189.36
Net Cash used in Investing Activities	-298.16	-149.69	-61.50	-93.71	-84.42
Net Cash flow from Financing Activities	24.96	-69.28	-135.80	37.72	-113.66
Net Cash Flow	44.36	42.16	40.32	2.66	-8.77
Closing Cash & Cash Equivalent	131.93	87.58	45.42	5.09	2.44
Closing Cash & Cash Equivalent Growth (%)	50.65	92.83	792.01	109.04	-78.26
Total Debt/ CFO (x)	0.43	0.32	0.51	3.94	0.77

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	317.49	260.06	238.53	58.60	189.28
Net Cash used in Investing Activities	-298.14	-149.67	-61.50	-93.72	-84.42
Net Cash flow from Financing Activities	24.96	-69.28	-135.80	37.72	-113.66
Net Cash Flow	44.31	41.11	41.24	2.60	-8.80
Closing Cash & Cash Equivalent	130.38	86.07	44.96	3.72	1.12
Closing Cash & Cash Equivalent Growth (%)	51.49	91.44	1,109.05	233.22	-88.75
Total Debt/ CFO (x)	0.43	0.32	0.51	3.94	0.77

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	17.06	23.40	16.46	7.60	10.26
Return on Capital Employed (%)	16.23	29.57	20.05	9.37	12.88
Return on Assets (%)	11.93	16.37	10.35	4.61	6.08
Interest Coverage Ratio (x)	41.43	33.94	21.55	10.72	6.89
Asset Turnover Ratio (x)	0.74	0.91	0.80	0.70	70.72
Price to Earnings (x)	60.24	27.03	14.20	20.79	33.44
Price to Book (x)	10.22	6.32	2.34	1.58	3.43
EV/EBITDA (x)	44.96	16.98	8.47	10.61	17.31
EBITDA Margin (%)	23.27	30.48	23.63	15.21	17.38

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	17.10	23.48	16.51	7.61	10.28
Return on Capital Employed (%)	16.25	29.68	20.13	9.39	12.92
Return on Assets (%)	11.91	16.36	10.32	4.59	6.06
Interest Coverage Ratio (x)	41.32	33.90	21.51	10.69	6.86
Asset Turnover Ratio (x)	0.74	0.91	0.80	0.70	70.78
Price to Earnings (x)	60.24	27.10	14.25	20.88	33.56
Price to Book (x)	10.27	6.35	2.35	1.59	3.45
EV/EBITDA (x)	45.09	17.01	8.48	10.65	17.35
EBITDA Margin (%)	23.21	30.44	23.59	15.16	17.34

Neuland Labs

Income (P&L)
Cash Flow

- Quarterly Topline Performance
  Company witnessed QoQ revenue growth of 71.68%, which is highest in the last 3 years. (Source: Consolidated Financials)
- Topline Contraction
  Sales de-grew by 4.7%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
- Increase in Cash from Investing
  Company has used Rs 298.16 cr for investing activities which is an YoY increase of 99.19%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Share Price Forecast

Price
Revenue
Earnings

Get multiple analysts’ prediction on Neuland Labs
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Neuland Labs
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Neuland Labs
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Bullish / Bearish signals for Neuland Labs basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 8 Jan 2026
5D EMA: 14933.84
Last 4 Sell Signals:5 Jan 2026
Date 7 days Gain/Loss %
5 Jan 2026 -3.89%
1 Jan 2026 -0.53%
22 Dec 2025 -5.61%
16 Dec 2025 -4.08%
Average price decline of -3.99% within 7 days of Bearish signal in last 5 years
10 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 8 Jan 2026
10D EMA: 15068.85
Last 4 Sell Signals:8 Dec 2025
Date 7 days Gain/Loss %
8 Dec 2025 -0.72%
1 Dec 2025 -4.23%
18 Nov 2025 -7.10%
24 Oct 2025 -4.66%
Average price decline of -3.72% within 7 days of Bearish signal in last 5 years
44%
Positive Movement since
1st Jan 2005 on basis
54%
Negative Movement since
1st Jan 2005 on basis
Exclude
Global Meltdown - 1st Jan 2008 to 10th Nov 2008
Covid Crisis - 1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3
Classic 9746.67 4873.33 4873.33 4873.33 9746.67 4873.33 4873.33
Average True Range
5 DAYS 14 DAYS 28 DAYS
ATR 3339.42 1542.71 1069.06

Date	7 days Gain/Loss %
5 Jan 2026	-3.89%
1 Jan 2026	-0.53%
22 Dec 2025	-5.61%
16 Dec 2025	-4.08%

Date	7 days Gain/Loss %
8 Dec 2025	-0.72%
1 Dec 2025	-4.23%
18 Nov 2025	-7.10%
24 Oct 2025	-4.66%

	R1	R2	R3	PIVOT	S1	S2	S3
Classic	9746.67	4873.33	4873.33	4873.33	9746.67	4873.33	4873.33

	5 DAYS	14 DAYS	28 DAYS
ATR	3339.42	1542.71	1069.06

Peer Comparison

Neuland Labs Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Neuland Labs Stock Performance	-0.47	-2.23	-8.55	-9.87	4.70	761.58	1089.24
Wockhardt Stock Performance	-0.72	-4.03	3.92	-1.74	0.41	521.95	173.59
Eris Lifesciences Stock Performance	-0.97	-3.09	-4.95	-6.37	16.07	133.70	142.56
OneSource Specialty Stock Performance	-1.28	-3.27	6.28	-7.09	0.00	0.00	0.00
Sai Life Science Ltd. Stock Performance	-3.25	0.00	0.00	0.00	0.00	0.00	0.00
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Neuland Labs	78.56	12.37	17.06	16.23	11.93	16.07	18.83	17.61	202.74	2.45	0.09	0.43
Wockhardt	-984.70	4.86	-1.07	3.90	-0.57	-1.82	7.90	-1.89	-3.02	1.26	0.43	-84.50
Eris Lifesciences	48.97	6.22	12.32	12.74	5.00	28.16	24.88	12.94	25.85	0.89	0.85	2.27
OneSource Specialty	498.21	3.38	-0.30	3.26	-0.23	121.23	14.54	-1.24	-1.63	0.98	0.13	-11.37
Sai Life Science Ltd.	65.44	8.81	7.99	12.51	5.38	24.20	17.93	10.03	8.83	2.05	0.06	0.41
Add More

Annual Ratios (%)

Choose from Peers

Jubilant Life
Alembic Pharma
Natco Pharma
Concord Biotech Ltd.
Caplin Point

Choose from Stocks

See All Parameters

Neuland Labs

Do you find these insights useful?

hate it
meh
love it

Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Neuland Labs Shareholding as on Dec 2025
Category Dec 2025 Sep 2025 Jun 2025 Mar 2025
Promoters 32.63 32.64 32.68 32.68
Pledge 0.00 0.00 0.00 0.00
FII 20.90 20.59 21.68 22.11
DII 14.71 13.54 11.57 10.96
Mutual Funds 10.39 9.78 7.66 7.43
Others 31.75 33.22 34.06 34.25
Showing Shareholding as on Dec 2025
Category No. of Shares Percentage % Change QoQ
Promoters 41,86,984 32.63 % 0.00
Pledge 0 0.00 % 0.00
FII 26,81,127 20.90 % 0.30
DII 18,85,870 14.71 % 1.16
MF 13,32,513 10.39 % 0.61
Others 40,75,908 31.75 % -1.46

Category	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Promoters	32.63	32.64	32.68	32.68
Pledge	0.00	0.00	0.00	0.00
FII	20.90	20.59	21.68	22.11
DII	14.71	13.54	11.57	10.96
Mutual Funds	10.39	9.78	7.66	7.43
Others	31.75	33.22	34.06	34.25

Category	No. of Shares	Percentage	% Change QoQ
Promoters	41,86,984	32.63 %	0.00
Pledge	0	0.00 %	0.00
FII	26,81,127	20.90 %	0.30
DII	18,85,870	14.71 %	1.16
MF	13,32,513	10.39 %	0.61
Others	40,75,908	31.75 %	-1.46

MF Ownership

ICICI Pru Flexicap Direct-G
Equity: Flexi Cap
4
- 468.23
  Amount Invested (in Cr.)
- 2.33476085%
  % of AUM
- 0.00
  % Change (MoM basis)
HSBC Small Cap Direct-G
Equity: Small Cap
3
- 279.58
  Amount Invested (in Cr.)
- 1.73%
  % of AUM
- -3.00
  % Change (MoM basis)
Bajaj Finserv Flexi Cap Direct-G
Equity: Flexi Cap
- 160.11
  Amount Invested (in Cr.)
- 2.54%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 30 November 2025

View all Mutual Fund Schemes

Corporate Actions

Neuland Labs Board Meeting/AGM
Neuland Labs Dividends
Others

Meeting Date	Announced on	Purpose	Details
Nov 07, 2025	Oct 24, 2025	Board Meeting	Quarterly Results
Sep 28, 2025	Aug 26, 2025	POM	-
Jul 31, 2025	Jul 14, 2025	Board Meeting	Quarterly Results
Jul 30, 2025	May 15, 2025	AGM	-
May 15, 2025	Apr 24, 2025	Board Meeting	Audited Results & Final Dividend

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	120%	12.0	Jul 18, 2025	May 15, 2025
Final	140%	14.0	Jul 12, 2024	May 10, 2024
Final	100%	10.0	Jul 11, 2023	May 11, 2023
Final	50%	5.0	Jul 14, 2022	May 10, 2022
Final	30%	3.0	Jun 29, 2021	May 11, 2021

All Types	Ex-Date	Record Date	Announced on	Details
Rights	Aug 13, 2014	Aug 14, 2014	Feb 05, 2014	Rights ratio: 4 share for every 25 held at a price of Rs 204.0
Rights	Mar 21, 2012	Mar 23, 2012	Jul 07, 2011	Rights ratio: 5 share for every 12 held at a price of Rs 45.0
Rights	Jan 22, 1996	Feb 15, 1996	Jan 18, 1996	Rights ratio: 1 share for every 2 held at a price of Rs 60.0
Rights	-	-	Oct 25, 1999	Rights ratio: 1 share for every 2 held at a price of Rs 60.0

About Neuland Labs

Neuland Laboratories Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 18,866.35 Crore) operating in Pharmaceuticals sector. Neuland Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients, Sale of services, Export Incentives, Scrap and Other Operating Revenue for the year ending 31-Mar-2025. Show More

Executives
Auditors

DR
Davuluri Rama Mohan Rao
Executive Chairman
DS
Davuluri Saharsh Rao
Vice Chairman & Mng.Director
DS
Davuluri Sucheth Rao
Vice Chairman & CEO
CM
Christopher M Cimarusti
Non Executive Director
HR
Homi Rustum Khusrokhan
Ind. Non-Executive Director
PJ
Pallavi Joshi Bakhru
Ind. Non-Executive Director
PR
Prasad Raghava Menon
Ind. Non-Executive Director
SS
Sugata Sircar
Ind. Non-Executive Director
AM
Abhijit Majumdar
Chief Financial Officer
SB
Sarada Bhamidipati
Co. Secretary & Compl. Officer
Show More
MSKA & Associates

Industry

Pharma - Indian

Key Indices Listed on

Nifty Smallcap 100, Nifty 500, BSE 500, + 17 more

Address

11th Floor (5th Office Level),Phoenix IVY Building,Plot No.573A-III,Hyderabad, Telangana - 500033

Contact

[email protected]

http://www.neulandlabs.com

More Details

FAQs about Neuland Labs share

1. What's the Neuland Labs share price today?
Neuland Labs share price is Rs 14,620.00 as on 13 Jan, 2026, 09:05 AM IST. Neuland Labs share price is down by 0.58% based on previous share price of Rs 14,774. Neuland Labs share price trend:
- Last 3 Years: Neuland Labs Share price moved up by 764.65%
2. What are the returns for Neuland Labs share?
Return Performance of Neuland Labs Shares:
- 1 Week: Neuland Labs share price moved up by 0.77%
3. What's the market capitalization of Neuland Labs?
Neuland Labs share has a market capitalization of Rs 18,866.35 Cr. Within Pharmaceuticals sector, it's market cap rank is 29.
4. What is 52 week high/low of Neuland Labs share price?
In last 52 weeks Neuland Labs share had a high price of Rs 19,747.00 and low price of Rs 10,190.70
5. What is the PE & PB ratio of Neuland Labs?
The PE ratio of Neuland Labs stands at 78.56, while the PB ratio is 12.44.

Trending in Markets

Top Gainers As on 03:58 PM | 12 Jan 2026

IFCI56.43

7.43 (15.14%)

Force Motors19,900.00

1190.00 (6.37%)

Hind Copper545.70

24.91 (4.79%)

BSE2,790.60

121.10 (4.54%)

Premier Energies745.60

28.15 (3.93%)

Top Losers As on 03:59 PM | 12 Jan 2026

Tejas Networks377.60

-39.55 (-9.49%)

City Union Bank263.05

-18.06 (-6.43%)

GE T&D India 2,718.20

-179.91 (-6.21%)

Signatureglobal India955.60

-52.00 (-5.17%)

Reliance Infra148.51

-7.82 (-5.00%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

1 Day	1.98%
1 Week	3.57%
1 Month	-6.7%
3 Months	-8.12%
1 Year	14.57%
3 Years	789.73%
5 Years	1116.59%

ETPrime

Neuland Labs - Neuland Laboratories Share Price

Key Metrics

Neuland Labs share price insights

InsightsNeuland Labs

Key Metrics

Neuland Labs Share Price Returns

ET Stock ScreenersTop Score Companies

News & Analysis

Share Recommendations

Recent Recos

Analyst Trends

Financials

Insights

Insights

Neuland Labs

Share Price Forecast

Get multiple analysts’ prediction on Neuland Labs

Get multiple analysts’ prediction on Neuland Labs

Get multiple analysts’ prediction on Neuland Labs

Technicals

Pivot Levels

Average True Range

Peer Comparison

Ratio Performance

Neuland Labs

Shareholding Pattern

MF Ownership

ICICI Pru Flexicap Direct-G

HSBC Small Cap Direct-G

Bajaj Finserv Flexi Cap Direct-G

Corporate Actions

About Neuland Labs

Executives

Auditors

More Details

FAQs about Neuland Labs share

Trending in Markets

Top Gainers As on 03:58 PM | 12 Jan 2026

Top Losers As on 03:59 PM | 12 Jan 2026

Neuland Labs Quick Links

Equity Quick Links

More from Markets